Remove business banking
article thumbnail

STAT+: CVS is willing to dump 10% of its Medicare Advantage members next year

STAT

CVS Health is preparing to make significant changes to its 2025 Medicare Advantage plans, which could potentially drive away 10% of its membership, the company’s chief financial officer said at an investment banking conference Tuesday. And that’s OK, because we need to get this business back on track.

331
331
article thumbnail

STAT+: Morgan Health wants you to know it’s still here

STAT

SAN FRANCISCO  — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

285
285
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: SVB, biotech’s bank of choice, just failed. It could have ripple effects

STAT

Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech companies, failed on Friday. Now, as federal regulators step in to clean up SVB’s mess, biotech startups are left wondering: What happens to their money, and who’s going to finance the industry?

363
363
article thumbnail

Pfizer, AstraZeneca to invest nearly $1 bn in France

Express Pharma

Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit. Pfizer said it would invest 500 million euros ($538.5

74
article thumbnail

Newsletter – April 2024

Fuld & Company Blog

Discover how boutique investment banks are leveraging research and analytics to close deals faster. Read about our recent strategy workshop with a metal manufacturer, where we helped them identify and evaluate new growth opportunities. Learn more about Shell’s significant strategy shift in the energy sector.

52
article thumbnail

Global Technology Firm Streamlines Inventory Management and Boosts Liquidity by Partnering With GEP

Pharma and Life Sciences Blog

How can businesses implement just-in-case inventory scenarios without hurting their cash flow? The solution helped the client free up $1 billion in working capital and was delivered by a company formed by GEP along with a bank and an equity firm. But the cost of holding inventory reserves is high.

52
article thumbnail

HSBC acquisition of SVB UK may result in for new opportunities for biopharma: GlobalData

Express Pharma

HSBC’s acquisition of Silicon Valley Bank UK following the collapse of its parent company Silicon Valley Bank may result in new opportunities for biopharma companies, says GlobalData. It remains to be seen how the void left by the collapse of the bank will be filled and whether there could be a slowdown in venture debt.